Concepedia

Chris Ruel

CR

Statistics

Publications

3

Citations

120

H-Index

3

Active since

2019

Affiliations

City Of Hope National Medical Center(Current)

The University of Texas MD Anderson Cancer Center

Chris Ruel is an author at City Of Hope National Medical Center specializing in cancer pharmacology, pharmacology, and medicine.

Publications per year

2019–2022

3

Publications

3

Results of a prospective phase 2 study of pazopanib in patients with surgically unresectable or metastatic chondrosarcoma

Warren Chow, Paul Frankel, Chris Ruel et al. · Cancer · 2019 · 78 citations · Full text

, , +13

Phase 1 study of the Aurora kinase A inhibitor alisertib (MLN8237) combined with the histone deacetylase inhibitor vorinostat in lymphoid malignancies

Tanya Siddiqi, Paul Frankel, Jan H. Beumer et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2019 · 30 citations · Full text

, , +17

Pazopanib in Patients with Osteosarcoma Metastatic to the Lung: Phase 2 Study Results and the Lessons for Tumor Measurement

Paul Frankel, Chris Ruel, An Uche et al. · Journal of Oncology · 2022 · 12 citations · Full text

, , +16

1–3 of 3